Suche senden
Hochladen
Kshivets astana wscts2017
•
711 gefällt mir
•
4,889 views
Oleg Kshivets
Folgen
Esophageal Cancer: Surgery and Precise Prognosis
Weniger lesen
Mehr lesen
Gesundheit & Medizin
Melden
Teilen
Melden
Teilen
1 von 20
Jetzt herunterladen
Downloaden Sie, um offline zu lesen
Empfohlen
Kshivets aats new_york2019
Kshivets aats new_york2019
Oleg Kshivets
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets
Kshivets eacts milan2018
Kshivets eacts milan2018
Oleg Kshivets
Kshivets O. Cardioesophageal Cancer Surgery
Kshivets O. Cardioesophageal Cancer Surgery
Oleg Kshivets
Kshivets barcelona2016
Kshivets barcelona2016
Oleg Kshivets
Kshivets IASLC_Vienna2016
Kshivets IASLC_Vienna2016
Oleg Kshivets
Kshivets IASLC 2019
Kshivets IASLC 2019
Oleg Kshivets
Kshivets sso2013
Kshivets sso2013
Oleg Kshivets
Empfohlen
Kshivets aats new_york2019
Kshivets aats new_york2019
Oleg Kshivets
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets
Kshivets eacts milan2018
Kshivets eacts milan2018
Oleg Kshivets
Kshivets O. Cardioesophageal Cancer Surgery
Kshivets O. Cardioesophageal Cancer Surgery
Oleg Kshivets
Kshivets barcelona2016
Kshivets barcelona2016
Oleg Kshivets
Kshivets IASLC_Vienna2016
Kshivets IASLC_Vienna2016
Oleg Kshivets
Kshivets IASLC 2019
Kshivets IASLC 2019
Oleg Kshivets
Kshivets sso2013
Kshivets sso2013
Oleg Kshivets
Kshivets wscts2019 sofia
Kshivets wscts2019 sofia
Oleg Kshivets
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets
Kshivets iaslc toronto2018
Kshivets iaslc toronto2018
Oleg Kshivets
Kshivets wscts2018 ljubljana
Kshivets wscts2018 ljubljana
Oleg Kshivets
Kshivets O. Esophageal & Cardioesophageal Cancer Surgery
Kshivets O. Esophageal & Cardioesophageal Cancer Surgery
Oleg Kshivets
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets
Kshivets iaslc denver2021
Kshivets iaslc denver2021
Oleg Kshivets
Kshivets barcelona2019
Kshivets barcelona2019
Oleg Kshivets
PRECISE EARLY DETECTION OF LUNG CANCER AND IMMUNE CIRCUIT
PRECISE EARLY DETECTION OF LUNG CANCER AND IMMUNE CIRCUIT
Oleg Kshivets
Kshivets O. Esophagogastric Cancer Surgery
Kshivets O. Esophagogastric Cancer Surgery
Oleg Kshivets
Lung Cancer: 10-Year Survival
Lung Cancer: 10-Year Survival
Oleg Kshivets
Kshivets wscts2015
Kshivets wscts2015
Oleg Kshivets
Kshivets Hong Kong Sydney2020
Kshivets Hong Kong Sydney2020
Oleg Kshivets
Kshivets milan2014
Kshivets milan2014
Oleg Kshivets
Kshivets iaslc singapore2020
Kshivets iaslc singapore2020
Oleg Kshivets
2021 esmo world_gi_poster_kshivets
2021 esmo world_gi_poster_kshivets
Oleg Kshivets
Kshivets O. Cancer, Synergetics and Immune Circuit
Kshivets O. Cancer, Synergetics and Immune Circuit
Oleg Kshivets
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets
Kshivets iaslc denver2015
Kshivets iaslc denver2015
Oleg Kshivets
Kshivets O. Lung Cancer: Early Detection and Diagnosis
Kshivets O. Lung Cancer: Early Detection and Diagnosis
Oleg Kshivets
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...
Oleg Kshivets
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Oleg Kshivets
Weitere ähnliche Inhalte
Was ist angesagt?
Kshivets wscts2019 sofia
Kshivets wscts2019 sofia
Oleg Kshivets
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets
Kshivets iaslc toronto2018
Kshivets iaslc toronto2018
Oleg Kshivets
Kshivets wscts2018 ljubljana
Kshivets wscts2018 ljubljana
Oleg Kshivets
Kshivets O. Esophageal & Cardioesophageal Cancer Surgery
Kshivets O. Esophageal & Cardioesophageal Cancer Surgery
Oleg Kshivets
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets
Kshivets iaslc denver2021
Kshivets iaslc denver2021
Oleg Kshivets
Kshivets barcelona2019
Kshivets barcelona2019
Oleg Kshivets
PRECISE EARLY DETECTION OF LUNG CANCER AND IMMUNE CIRCUIT
PRECISE EARLY DETECTION OF LUNG CANCER AND IMMUNE CIRCUIT
Oleg Kshivets
Kshivets O. Esophagogastric Cancer Surgery
Kshivets O. Esophagogastric Cancer Surgery
Oleg Kshivets
Lung Cancer: 10-Year Survival
Lung Cancer: 10-Year Survival
Oleg Kshivets
Kshivets wscts2015
Kshivets wscts2015
Oleg Kshivets
Kshivets Hong Kong Sydney2020
Kshivets Hong Kong Sydney2020
Oleg Kshivets
Kshivets milan2014
Kshivets milan2014
Oleg Kshivets
Kshivets iaslc singapore2020
Kshivets iaslc singapore2020
Oleg Kshivets
2021 esmo world_gi_poster_kshivets
2021 esmo world_gi_poster_kshivets
Oleg Kshivets
Kshivets O. Cancer, Synergetics and Immune Circuit
Kshivets O. Cancer, Synergetics and Immune Circuit
Oleg Kshivets
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Oleg Kshivets
Kshivets iaslc denver2015
Kshivets iaslc denver2015
Oleg Kshivets
Kshivets O. Lung Cancer: Early Detection and Diagnosis
Kshivets O. Lung Cancer: Early Detection and Diagnosis
Oleg Kshivets
Was ist angesagt?
(20)
Kshivets wscts2019 sofia
Kshivets wscts2019 sofia
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Kshivets iaslc toronto2018
Kshivets iaslc toronto2018
Kshivets wscts2018 ljubljana
Kshivets wscts2018 ljubljana
Kshivets O. Esophageal & Cardioesophageal Cancer Surgery
Kshivets O. Esophageal & Cardioesophageal Cancer Surgery
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Kshivets iaslc denver2021
Kshivets iaslc denver2021
Kshivets barcelona2019
Kshivets barcelona2019
PRECISE EARLY DETECTION OF LUNG CANCER AND IMMUNE CIRCUIT
PRECISE EARLY DETECTION OF LUNG CANCER AND IMMUNE CIRCUIT
Kshivets O. Esophagogastric Cancer Surgery
Kshivets O. Esophagogastric Cancer Surgery
Lung Cancer: 10-Year Survival
Lung Cancer: 10-Year Survival
Kshivets wscts2015
Kshivets wscts2015
Kshivets Hong Kong Sydney2020
Kshivets Hong Kong Sydney2020
Kshivets milan2014
Kshivets milan2014
Kshivets iaslc singapore2020
Kshivets iaslc singapore2020
2021 esmo world_gi_poster_kshivets
2021 esmo world_gi_poster_kshivets
Kshivets O. Cancer, Synergetics and Immune Circuit
Kshivets O. Cancer, Synergetics and Immune Circuit
Kshivets O. Lung Cancer Surgery
Kshivets O. Lung Cancer Surgery
Kshivets iaslc denver2015
Kshivets iaslc denver2015
Kshivets O. Lung Cancer: Early Detection and Diagnosis
Kshivets O. Lung Cancer: Early Detection and Diagnosis
Ähnlich wie Kshivets astana wscts2017
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...
Oleg Kshivets
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Oleg Kshivets
Lung Cancer: Precise Prediction
Lung Cancer: Precise Prediction
Oleg Kshivets
Kshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdf
Oleg Kshivets
Kshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdf
Oleg Kshivets
Kshivets yokohama iaslc2017
Kshivets yokohama iaslc2017
Oleg Kshivets
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...
Oleg Kshivets
Kshivets ASCVTS Moscow2018
Kshivets ASCVTS Moscow2018
Oleg Kshivets
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Oleg Kshivets
Kshivets O. Esophageal and Cardioesophageal Cancer Surgery
Kshivets O. Esophageal and Cardioesophageal Cancer Surgery
Oleg Kshivets
RNA (gene expression) analysis of Prostate cancers and non-cancerous tissues t
RNA (gene expression) analysis of Prostate cancers and non-cancerous tissues t
Tsukuba GeneTechnology Laboratories, Ibaraki, JPN
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
Oleg Kshivets
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
Oleg Kshivets
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
Oleg Kshivets
Kshivets_SPB_WSCTS2022Lung.pdf
Kshivets_SPB_WSCTS2022Lung.pdf
Oleg Kshivets
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Oleg Kshivets
Kshivets ny2021aats
Kshivets ny2021aats
Oleg Kshivets
Kshivets_SPB_WSCTS2022Eso.pdf
Kshivets_SPB_WSCTS2022Eso.pdf
Oleg Kshivets
Esophageal Cancer: Precise Prediction
Esophageal Cancer: Precise Prediction
Oleg Kshivets
Kshivets barcelona2020
Kshivets barcelona2020
Oleg Kshivets
Ähnlich wie Kshivets astana wscts2017
(20)
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...
Kshivets Oleg Optimization of Management for Esophageal Cancer Patients (T1-...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Lung Cancer: Precise Prediction
Lung Cancer: Precise Prediction
Kshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdf
Kshivets_ELCC2023.pdf
Kshivets yokohama iaslc2017
Kshivets yokohama iaslc2017
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...
Combined Esophagogastrectomies: Survival Outcomes in Patients with Local Adva...
Kshivets ASCVTS Moscow2018
Kshivets ASCVTS Moscow2018
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Kshivets O. Esophageal and Cardioesophageal Cancer Surgery
Kshivets O. Esophageal and Cardioesophageal Cancer Surgery
RNA (gene expression) analysis of Prostate cancers and non-cancerous tissues t
RNA (gene expression) analysis of Prostate cancers and non-cancerous tissues t
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
KshivetsWSCTS2023_Brazil.pdf
Kshivets_SPB_WSCTS2022Lung.pdf
Kshivets_SPB_WSCTS2022Lung.pdf
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Survival of Lung Cancer Patients after Lobectomies was Significantly Superior...
Kshivets ny2021aats
Kshivets ny2021aats
Kshivets_SPB_WSCTS2022Eso.pdf
Kshivets_SPB_WSCTS2022Eso.pdf
Esophageal Cancer: Precise Prediction
Esophageal Cancer: Precise Prediction
Kshivets barcelona2020
Kshivets barcelona2020
Mehr von Oleg Kshivets
Kshivets_IASLC_Singapore2023.pdf
Kshivets_IASLC_Singapore2023.pdf
Oleg Kshivets
Kshivets_WCGIC2023.pdf
Kshivets_WCGIC2023.pdf
Oleg Kshivets
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...
Oleg Kshivets
• Gastric cancer prognosis and cell ratio factors
• Gastric cancer prognosis and cell ratio factors
Oleg Kshivets
Kshivets elcc2022
Kshivets elcc2022
Oleg Kshivets
Kshivets gc 10_ys_wjarr-2021-0659
Kshivets gc 10_ys_wjarr-2021-0659
Oleg Kshivets
Kshivets lc10 ys_wjarr
Kshivets lc10 ys_wjarr
Oleg Kshivets
Kshivets eso10 y2021
Kshivets eso10 y2021
Oleg Kshivets
Kshivets esmo2021
Kshivets esmo2021
Oleg Kshivets
Kshivets ASCO Chicago2020
Kshivets ASCO Chicago2020
Oleg Kshivets
Mehr von Oleg Kshivets
(10)
Kshivets_IASLC_Singapore2023.pdf
Kshivets_IASLC_Singapore2023.pdf
Kshivets_WCGIC2023.pdf
Kshivets_WCGIC2023.pdf
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...
Lung cancer cell dynamics significantly depended on blood cell circuit, bioch...
• Gastric cancer prognosis and cell ratio factors
• Gastric cancer prognosis and cell ratio factors
Kshivets elcc2022
Kshivets elcc2022
Kshivets gc 10_ys_wjarr-2021-0659
Kshivets gc 10_ys_wjarr-2021-0659
Kshivets lc10 ys_wjarr
Kshivets lc10 ys_wjarr
Kshivets eso10 y2021
Kshivets eso10 y2021
Kshivets esmo2021
Kshivets esmo2021
Kshivets ASCO Chicago2020
Kshivets ASCO Chicago2020
Kürzlich hochgeladen
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
saminamagar
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
narwatsonia7
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
vijaych2041
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
sonalikaur4
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
Niranjan Chavan
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
narwatsonia7
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
narwatsonia7
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
narwatsonia7
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
narwatsonia7
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
Arunagarwal328757
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
parulsinha
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
narwatsonia7
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
narwatsonia7
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
saminamagar
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
narwatsonia7
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
narwatsonia7
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
jennyeacort
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
Nehru place Escorts
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
MedicoseAcademics
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Nehru place Escorts
Kürzlich hochgeladen
(20)
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kshivets astana wscts2017
1.
ESOPHAGEAL CANCER: SURGERY AND
PRECISE PROGNOSIS Kshivets Oleg, MD, PhD Surgery Department, Roshal Hospital, Roshal, Moscow, Russia
2.
ABSTRACT ESOPHAGEAL CANCER: SURGERY
AND PRECISE PROGNOSIS BACKGROUND: We examined factors in terms of precise prognosis of 5-year survival (5YS) of esophageal cancer (EC) patients (ECP) (T1-4N0-2M0) after complete (R0) esophagogastrectomies (EG). METHODS: We analyzed data of 515 consecutive ECP (age=56.3±8.9 years; tumor size=6.2±3.4 cm) radically operated and monitored in 1975-2017 (m=380, f=135; esophagogastrectomies (EG) Garlock=280, EG Lewis=235, combined EG with resection of pancreas, liver, diaphragm, aorta, VCS, colon transversum, lung, trachea, pericardium, splenectomy=151; adenocarcinoma=292, squamous=213, mix=10; T1=101, T2=114, T3=175, T4=125; N0=248, N1=69, N2=198; G1=148, G2=125, G3=242; early EC=82, invasive=433; only surgery=394, adjuvant chemoimmunoradiotherapy-AT=121: 5- FU+thymalin/taktivin+radiotherapy 45-50Gy). Multivariate Cox modeling, clustering, SEPATH, Monte Carlo, bootstrap and neural networks computing were used to determine any significant dependence. RESULTS: Overall life span (LS) was 1814.5±2225.6 days and cumulative 5YS reached 48.8%, 10 years – 42.3%, 20 years – 31.7%. 160 ECP lived more than 5 years (LS=4384.1±2474.1 days), 89 ECP – more than 10 years (LS=5913.1±2360.3 days). 224 ECP died because of EC (LS=629.2±320.1 days). AT significantly improved 5YS (67.6% vs. 44.6%) (P=0.00008 by log-rank test). Cox modeling displayed that 5YS of ECP significantly depended on: phase transition (PT) N0—N12 in terms of synergetics, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), T, G, age, AT, localization, blood cells, prothrombin index, coagulation time, residual nitrogen , RH (P=0.000-0.026). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and healthy cells/CC (rank=1), PT early-invasive EC (rank=2), thrombocytes/CC (3), PT N0—N12 (4), erythrocytes/CC (5), stick neutrophils/CC (6), segmented neutrophils/CC (7), lymphocytes/CC (8), leucocytes/CC (9), eosinophils/CC (10), monocytes/CC (11) . Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0 ). CONCLUSIONS: 5YS of ECP after radical procedures significantly depended on: 1) PT “early-invasive cancer”; 2) PT N0-- N12; 3) Cell Ratio Factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) EC characteristics; 9) tumor localization; 10) anthropometric data.
3.
DATA: Males…………………………………………………………………….380 Females………..…………………………….....................................135 Age=56.3±8.9 years Tumor Size=6.2±3.4
cm Only Surgery.…………………………………..................................394 Adjuvant Chemoimmunoradiotherapy (5FU+thymalin/taktivin, 5-6 cycles+ Radiotherapy 45-50Gy)....121
4.
RADICAL PROCEDURES: Esophagogastrectomies Lewis
(R0)……………………………...…235 Esophagogastrectomies Garlock (R0)………................................280 Combined Esophagogastrectomies with Resection of Pancreas, Liver, Trachea, Lung, Aorta, Vena Cava Superior, Colon Transversum, Diaphragm, Pericardium, Splenectomy (R0)…….151 2-Field Lymphadenectomy…………………………………………....364 3-Field Lymphadenectomy.……………………………………...……151
5.
STAGING: T1……..101 N0..……248 G1…………148 T2……..114
N1…........69 G2…………125 T3……..175 N2…......198 G3…………242 T4……..125 M0……...515 Adenocarcinoma………………………………..292 Squamos Cell Carcinoma……………………..213 Mix………………….....…………………...............10 Early Cancer……………………………...………..82 Invasive Cancer…………………………..……...433
6.
SURVIVAL RATE: Alive………………………………………............................260
(50.5%) 5-Year Survivors…………..…………………………..........160 (31.1%) 10-Year Survivors…………………………...........................89 (17.3%) Losses………………………..……………………………….224 (43.5%) General Life Span=1814.5±2225.6 days For 5-Year Survivors=4384.1±2474.1 days For 10-Year Survivors=5913.1±2360.3 days For Losses=629.2±320.1 days Cumulative 5-Year Survival…………………….48.8% Cumulative 10-Year Survival…………………...42.3% Cumulative 20-Year Survival…………………...31.7%
7.
GENERAL ESOPHAGEAL CANCER
PATIENTS SURVIVAL AFTER COMPLETE ESOPHAGOGASTRECTOMIES (KAPLAN-MEIER) (N=515):
8.
RESULTS OF UNIVARIATE
ANALYSIS OF PHASE TRANSITION EARLY—INVASIVE CANCER IN PREDICTION OF ESOPHAGEAL CANCER PATIENTS SURVIVAL (N=515):
9.
RESULTS OF UNIVARIATE
ANALYSIS OF PHASE TRANSITION N0—N1-2 IN PREDICTION OF ESOPHAGEAL CANCER PATIENTS SURVIVAL (N=515):
10.
RESULTS OF UNIVARIATE
ANALYSIS OF ADJUVANT CHEMOIMMUNORADIOTHERAPY IN PREDICTION OF ESOPHAGEAL CANCER PATIENTS SURVIVAL (N=515):
11.
RESULTS OF UNIVARIATE
ANALYSIS OF LOCALIZATION (UPPER/3 VS. MIDDLE/3 & LOWER/3) IN PREDICTION OF ESOPHAGEAL CANCER PATIENTS SURVIVAL (N=515):
12.
RESULTS OF COX
REGRESSION MODELING IN PREDICTION OF ESOPHAGEAL CANCER PATIENTS SURVIVAL AFTER COMPLETE ESOPHAGOGASTRECTOMIES (N=515): Cox Regression: Factors Parameter Estimate Standard Error Chi- square P value 95% Lower CL 95% Upper CL Hazard Ratio Rh-factor -0.45229 0.176756 6.54776 0.010502 -0.79873 -0.105858 0.636168 Hemorrhage Time 0.00126 0.000433 8.40139 0.003749 0.00041 0.002105 1.001257 Glucose -0.18331 0.084425 4.71444 0.029910 -0.34878 -0.017840 0.832511 Residual Nitrogen 0.05237 0.011983 19.10326 0.000012 0.02889 0.075860 1.053770 Protein 0.02949 0.009120 10.45502 0.001223 0.01161 0.047361 1.029926 Prothrombin Index 0.02483 0.007028 12.48251 0.000411 0.01106 0.038606 1.025142 T1-4 0.38912 0.098018 15.76015 0.000072 0.19701 0.581233 1.475684 Phase Transition N0---N1-2 0.64369 0.165528 15.12176 0.000101 0.31926 0.968115 1.903483 Age 0.03037 0.008013 14.36858 0.000150 0.01467 0.046077 1.030839 Histology -0.29687 0.131185 5.12126 0.023634 -0.55399 -0.039757 0.743137 G1-3 0.40780 0.091366 19.92147 0.000008 0.22872 0.586871 1.503502 Adjuvant Chemoimmunoradiotherapy -0.85863 0.200235 18.38792 0.000018 -1.25108 -0.466177 0.423742 Leucocytes (tot) -1.47405 0.367150 16.11886 0.000059 -2.19365 -0.754444 0.228997 Eosinophils (tot) 1.84217 0.421596 19.09271 0.000012 1.01586 2.668487 6.310240 Stick Neutrophils (tot) 1.26769 0.347754 13.28861 0.000267 0.58610 1.949274 3.552630 Segmented Neutrophils (tot) 1.49871 0.369391 16.46123 0.000050 0.77472 2.222700 4.475901 Leucocytes/Cancer Cells 1.43528 0.626593 5.24687 0.021986 0.20718 2.663375 4.200804 Eosinophils/Cancer Cells -4.02473 1.558966 6.66499 0.009832 -7.08024 -0.969211 0.017868 Segmented Neutrophils/Cancer Cells -1.59111 0.666185 5.70439 0.016923 -2.89680 -0.285408 0.203700 Lymphocytes/Cancer Cells -1.68907 0.762446 4.90766 0.026738 -3.18343 -0.194699 0.184692 Lymphocytes (tot) 1.47963 0.374498 15.61013 0.000078 0.74563 2.213633 4.391320 Monocytes (tot) 1.17235 0.358303 10.70567 0.001068 0.47009 1.874612 3.229575 Localization: Upper/3 vs. Others/3 -0.53733 0.196847 7.45108 0.006340 -0.92314 -0.151514 0.584309
13.
RESULTS OF DISCRIMINANT
FUNCTION ANALYSIS IN PREDICTION OF ESOPHAGEAL CANCER PATIENTS SURVIVAL AFTER COMPLETE ESOPHAGOGASTRECTOMIES (N=384): Discriminant Function Analysis Summary Wilks' Lambda: .45402 approx. F (18,365)=24.385 p<0.0000 Factors Wilks' - Lambda Partial - Lambda F-remove - (1,365) p-value Toler. 1-Toler. - (R-Sqr.) Rh-factor 0.465749 0.974809 9.43249 0.002292 0.906600 0.093400 HB 0.468602 0.968873 11.72619 0.000686 0.850765 0.149235 Hemorrhage Time 0.461163 0.984502 5.74568 0.017031 0.892014 0.107986 Residual Nitrogen 0.491681 0.923395 30.28066 0.000000 0.794226 0.205774 Stick Neutrophils (abs) 0.462830 0.980957 7.08579 0.008113 0.021425 0.978575 Segmented Neutrophils (abs) 0.462213 0.982266 6.58971 0.010655 0.119903 0.880097 T1-4 0.480596 0.944693 21.36875 0.000005 0.549885 0.450115 Phase Transition N0---N1-2 0.488041 0.930283 27.35391 0.000000 0.709487 0.290513 G1-3 0.465201 0.975956 8.99241 0.002897 0.867697 0.132303 Tumor Growth 0.469517 0.966985 12.46197 0.000468 0.646569 0.353431 Adjuvant Chemoimmunoradiotherapy 0.480222 0.945429 21.06826 0.000006 0.806219 0.193781 Combined Procedure 0.466634 0.972958 10.14446 0.001572 0.785403 0.214598 Phase Transition Early---Invasive Cancer 0.476821 0.952172 18.33426 0.000024 0.533466 0.466534 Leucocytes (tot) 0.464663 0.977086 8.55995 0.003651 0.000260 0.999740 Eosinophils (tot) 0.461626 0.983514 6.11822 0.013834 0.059994 0.940006 Segmented Neutrophils (tot) 0.465465 0.975402 9.20488 0.002587 0.000461 0.999539 Lymphocytes (tot) 0.464409 0.977622 8.35510 0.004076 0.003106 0.996894 Monocytes (tot) 0.464288 0.977876 8.25781 0.004295 0.029356 0.970644
14.
RESULTS OF NEURAL
NETWORKS COMPUTING IN PREDICTION OF ESOPHAGEAL CANCER PATIENTS SURVIVAL AFTER COMPLETE ESOPHAGOGASTRECTOMIES (N=384): Corect Classification Rate=100% Error=0.000 Area under ROC Curve=1.000 Factors: Rank Sensitivity Healthy Cells/Cancer Cells Phase Transition Early---Invasive Thrombocytes/Cancer Cells Phase Transition N0---N12 Erythrocytes/Cancer Cells Stick Neutrophils/Cancer Cells Segmented Neutrophils/Cancer Cells Lymphocytes/Cancer Cells Leucocytes/Cancer Cells Eosinophils/Cancer Cells Monocytes/Cancer Cells 1 2 3 4 5 6 7 8 9 10 11 17383 13238 9124 8767 4909 4418 4043 3705 2808 2330 1792
15.
RESULTS OF BOOTSTRAP
SIMULATION IN PREDICTION OF ESOPHAGEAL CANCER PATIENTS SURVIVAL AFTER ESOPHAGOGASTRECTOMIES (N=384): Significant Factors (Number of Samples=3333) Rank Kendal Tau-A P Tumor Size 1 -0.290 0.000 Healthy Cells/Cancer Cells 2 0.288 0.000 T1-4 3 -0.280 0.000 Erythrocytes/Cancer Cells 4 0.278 0.000 Leucocytes/Cancer Cells 5 0.268 0.000 Thrombocytes/Cancer Cells 6 0.265 0.000 Lymphocytes/Cancer Cells 7 0.259 0.000 Segmented Neutrophils/Cancer Cells 8 0.249 0.000 Residual Nitrogen 9 -0.243 0.000 Phase Transition N0---N12 10 -0.228 0.000 Monocytes/Cancer Cells 11 0.223 0.000 Hemorrhage Time 12 -0.223 0.000 Phase Transition Early---Invasive Cancer 13 -0.189 0.000 Eosinophils/Cancer Cells 14 0.163 0.000 Chlorides 15 0.162 0.000 Stick Neutrophils/Cancer Cells 16 0.152 0.000 Tumor Growth 17 -0.131 0.000 G1-3 18 -0.128 0.000 Glucose 19 0.087 0.05 Erythrocytes 20 0.080 0.05 Weight 21 0.080 0.05 Localization 22 0.075 0.05
16.
RESULTS OF KOHONEN
SELF-ORGANIZING NEURAL NETWORKS COMPUTING IN PREDICTION OF ESOPHAGEAL CANCER PATIENTS SURVIVAL AFTER COMPLETE ESOPHAGOGASTRECTOMIES (N=384):
17.
ESOPHAGEAL CANCER DYNAMICS:
18.
PROGNOSTIC SEPATH-MODEL OF
ESOPHAGEAL CANCER PATIENTS SURVIVAL AFTER COMPLETE ESOPHAGOGASTRECTOMIES (N=384):
19.
5-YEAR SURVIVAL OF
ESOPHAGEAL CANCER PATIENTS AFTER RADICAL PROCEDURES SIGNIFICANTLY DEPENDED ON: 1) PHASE TRANSITION “EARLY-INVASIVE CANCER”; 2) PHASE TRANSITION N0--N12; 3) CELL RATIO FACTORS; 4) BLOOD CELL CIRCUIT; 5) BIOCHEMICAL FACTORS; 6) HEMOSTASIS SYSTEM; 7) ADJUVANT CHEMOIMMUNORADIOTHERAPY; 8) CANCER CHARACTERISTICS ; 9) TUMOR LOCALIZATION; 10) ANTHROPOMETRIC DATA. Conclusion:
20.
ADDRESS: OLEG KSHIVETS, M.D.,PH.D. CONSULTANT
THORACIC, ABDOMINAL, GENERAL SURGEON & SURGICAL ONCOLOGIST e-mail: okshivets@yahoo.com skype: okshivets http: //www.ctsnet.org/home/okshivets
Jetzt herunterladen